Grace Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
Grace Therapeutics, Inc. (GRCE) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $0 for the 12-month period ending 2025-03-31, per its 10-K filed 2025-06-23.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2025-06-23
- Grace Therapeutics, Inc. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2025 was $0.00.
- Grace Therapeutics, Inc. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2024 was -$486.00K.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|
| 2025-03-31 | $0.00 10-K · filed 2025-06-23 |
| 2024-03-31 | -$486.00K 10-K · filed 2025-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |